CROSS HERB

Chief Financial Officer at Jasper Therapeutics, Inc. · on record since Sep 26, 2023
Corp Controller/Prin Acctg Off at PDL BIOPHARMA, INC. · on record since Sep 17, 2007
Chief Financial Officer at HUMANIGEN, INC · on record since Oct 23, 2013
VP of Finance/Prin Acctg Off at ABBOTT BIOTHERAPEUTICS CORP · on record since Apr 21, 2010
Chief Financial Officer at AFFYMAX INC · on record since Mar 7, 2011
Chief Financial Officer at ARMO BioSciences, Inc. · on record since Jan 25, 2018
VP of Finance at NEOFORMA INC · on record since Feb 23, 2005
Chief Financial Officer at Atreca, Inc. · on record since Jun 19, 2019
Director at Apexigen, Inc. · on record since Aug 8, 2022

Insider trading activity of CROSS HERB

Transactions on record: 94; since Aug 4, 2003

Open-market buys: 2; $22.7K

Open-market sells: 13; $778.9K

Companies traded: 9; last filing Jan 5, 2026

Figures computed from official regulatory filings — .

Companies where CROSS HERB has traded

Jasper Therapeutics, Inc.5 tx · Jan 5, 2026
Apexigen, Inc.3 tx · Aug 25, 2023
Atreca, Inc.14 tx · $18.8K · Aug 4, 2023
ARMO BioSciences, Inc.1 tx · $10.4M · Jun 22, 2018
HUMANIGEN, INC13 tx · Nov 10, 2015
AFFYMAX INC16 tx · $673.8K · Feb 1, 2013
17 tx · $1.3M · Apr 23, 2010
4 tx · $6.8K · Sep 17, 2008
21 tx · $532.8K · Jan 13, 2006

Track record of CROSS HERB

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of CROSS HERB

Co-insiders of CROSS HERB

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Jasper Therapeutics, Inc.Listing on record	Jan 5, 2026	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jasper Therapeutics, Inc.Listing on record	Jun 6, 2025	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jasper Therapeutics, Inc.Listing on record	Feb 18, 2025	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jasper Therapeutics, Inc.Listing on record	Feb 20, 2024	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jasper Therapeutics, Inc.Listing on record	Sep 26, 2023	AwardD (derivative)	550,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Apexigen, Inc.Listing unverified	Aug 25, 2023	OtherD (derivative)	-100,000	—	n/a (No price was disclosed in the filing)		SEC
Apexigen, Inc.Listing unverified	Aug 25, 2023	OtherD (derivative)	-34,084	—	n/a (No price was disclosed in the filing)		SEC
Atreca, Inc.Listing unverified	Aug 4, 2023	Sell	-5,487	0.95 USD	$5.2K		SEC
Atreca, Inc.Listing unverified	Feb 13, 2023	AwardD (derivative)	175,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Feb 13, 2023	Award	43,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Apexigen, Inc.Listing unverified	Oct 3, 2022	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Sep 20, 2022	Sell	-7,646	1.78 USD	$13.6K		SEC
Atreca, Inc.Listing unverified	Jun 15, 2022	OtherD (derivative)	-97,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Jun 15, 2022	OtherD (derivative)	-95,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Jun 15, 2022	OtherD (derivative)	-224,999	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Jun 15, 2022	AwardD (derivative)	224,999	—	n/a (No price was disclosed in the filing)		SEC
Atreca, Inc.Listing unverified	Jun 15, 2022	AwardD (derivative)	97,000	—	n/a (No price was disclosed in the filing)		SEC
Atreca, Inc.Listing unverified	Jun 15, 2022	AwardD (derivative)	95,000	—	n/a (No price was disclosed in the filing)		SEC
Atreca, Inc.Listing unverified	Dec 28, 2021	AwardD (derivative)	95,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Sep 13, 2021	Award	42,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Jan 29, 2021	AwardD (derivative)	95,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Feb 28, 2020	AwardD (derivative)	97,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARMO BioSciences, Inc.Listing unverified	Jun 22, 2018	OtherD (derivative)	-240,658	43.03 USD	$10.4M	Unusual size	SEC
HUMANIGEN, INCListing unverified	Nov 10, 2015	AwardD (derivative)	1,875	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Oct 8, 2015	AwardD (derivative)	1,875	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Jasper Therapeutics, Inc.Listing on record	Jan 5, 2026	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jasper Therapeutics, Inc.Listing on record	Jun 6, 2025	AwardD (derivative)	90,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jasper Therapeutics, Inc.Listing on record	Feb 18, 2025	AwardD (derivative)	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jasper Therapeutics, Inc.Listing on record	Feb 20, 2024	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Jasper Therapeutics, Inc.Listing on record	Sep 26, 2023	AwardD (derivative)	550,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Apexigen, Inc.Listing unverified	Aug 25, 2023	OtherD (derivative)	-100,000	—	n/a (No price was disclosed in the filing)		SEC
Apexigen, Inc.Listing unverified	Aug 25, 2023	OtherD (derivative)	-34,084	—	n/a (No price was disclosed in the filing)		SEC
Atreca, Inc.Listing unverified	Aug 4, 2023	Sell	-5,487	0.95 USD	$5.2K		SEC
Atreca, Inc.Listing unverified	Feb 13, 2023	AwardD (derivative)	175,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Feb 13, 2023	Award	43,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Apexigen, Inc.Listing unverified	Oct 3, 2022	AwardD (derivative)	100,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Sep 20, 2022	Sell	-7,646	1.78 USD	$13.6K		SEC
Atreca, Inc.Listing unverified	Jun 15, 2022	OtherD (derivative)	-97,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Jun 15, 2022	OtherD (derivative)	-95,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Jun 15, 2022	OtherD (derivative)	-224,999	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Jun 15, 2022	AwardD (derivative)	224,999	—	n/a (No price was disclosed in the filing)		SEC
Atreca, Inc.Listing unverified	Jun 15, 2022	AwardD (derivative)	97,000	—	n/a (No price was disclosed in the filing)		SEC
Atreca, Inc.Listing unverified	Jun 15, 2022	AwardD (derivative)	95,000	—	n/a (No price was disclosed in the filing)		SEC
Atreca, Inc.Listing unverified	Dec 28, 2021	AwardD (derivative)	95,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Sep 13, 2021	Award	42,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Jan 29, 2021	AwardD (derivative)	95,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Atreca, Inc.Listing unverified	Feb 28, 2020	AwardD (derivative)	97,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ARMO BioSciences, Inc.Listing unverified	Jun 22, 2018	OtherD (derivative)	-240,658	43.03 USD	$10.4M	Unusual size	SEC
HUMANIGEN, INCListing unverified	Nov 10, 2015	AwardD (derivative)	1,875	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
HUMANIGEN, INCListing unverified	Oct 8, 2015	AwardD (derivative)	1,875	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC